Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith A Baggerly

Showing results (71-80 of 92) with videos related to

Pageof 10
Sort By:
European Urology|March 19, 2016
Gene Expression Profile of the Clinically Aggressive Micropapillary Variant of Bladder CancerCharles Chuanhai Guo, Vipulkumar Dadhania, Li Zhang, et al.
Cancer Biology & Therapy|April 24, 2014
Focal adhesion kinase: an alternative focus for anti-angiogenesis therapy in ovarian cancerRebecca L Stone, Keith A Baggerly, Guillermo N Armaiz-Pena, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 24, 2014
Molecular biomarkers of residual disease after surgical debulking of high-grade serous ovarian cancerSusan L Tucker, Kshipra Gharpure, Shelley M Herbrich, et al.
Molecular Systems Biology|December 15, 2015
A genome-scale screen reveals context-dependent ovarian cancer sensitivity to miRNA overexpressionBenjamin B Shields, Chad V Pecot, Hua Gao, et al.
Molecular Oncology|June 30, 2014
BRCA2 inhibition enhances cisplatin-mediated alterations in tumor cell proliferation, metabolism, and metastasisMateusz Rytelewski, Jessica G Tong, Adrian Buensuceso, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 27, 2004
Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysisKaren H Lu, Andrea P Patterson, Lin Wang, et al.
Cancer Biology & Therapy|April 28, 2009
Dual targeting of EphA2 and FAK in ovarian carcinomaMian M K Shahzad, Chunhua Lu, Jeong-Won Lee, et al.
Cancers|September 9, 2022
Molecular Analysis of Short- versus Long-Term Survivors of High-Grade Serous Ovarian CarcinomaElaine Stur, Emine Bayraktar, Graziela Zibetti Dal Molin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 2015
A Phase I/II Study of the mTOR Inhibitor Everolimus in Combination with HyperCVAD Chemotherapy in Patients with Relapsed/Refractory Acute Lymphoblastic LeukemiaNaval Daver, Yanis Boumber, Hagop Kantarjian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 4, 2014
Preclinical and early clinical evaluation of the oral AKT inhibitor, MK-2206, for the treatment of acute myelogenous leukemiaMarina Y Konopleva, Roland B Walter, Stefan H Faderl, et al.
Pageof 10

Showing results (71-80 of 92) with videos related to

Sort By:
Pageof 10
European Urology|March 19, 2016
Gene Expression Profile of the Clinically Aggressive Micropapillary Variant of Bladder CancerCharles Chuanhai Guo, Vipulkumar Dadhania, Li Zhang, et al.
Cancer Biology & Therapy|April 24, 2014
Focal adhesion kinase: an alternative focus for anti-angiogenesis therapy in ovarian cancerRebecca L Stone, Keith A Baggerly, Guillermo N Armaiz-Pena, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 24, 2014
Molecular biomarkers of residual disease after surgical debulking of high-grade serous ovarian cancerSusan L Tucker, Kshipra Gharpure, Shelley M Herbrich, et al.
Molecular Systems Biology|December 15, 2015
A genome-scale screen reveals context-dependent ovarian cancer sensitivity to miRNA overexpressionBenjamin B Shields, Chad V Pecot, Hua Gao, et al.
Molecular Oncology|June 30, 2014
BRCA2 inhibition enhances cisplatin-mediated alterations in tumor cell proliferation, metabolism, and metastasisMateusz Rytelewski, Jessica G Tong, Adrian Buensuceso, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 27, 2004
Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysisKaren H Lu, Andrea P Patterson, Lin Wang, et al.
Cancer Biology & Therapy|April 28, 2009
Dual targeting of EphA2 and FAK in ovarian carcinomaMian M K Shahzad, Chunhua Lu, Jeong-Won Lee, et al.
Cancers|September 9, 2022
Molecular Analysis of Short- versus Long-Term Survivors of High-Grade Serous Ovarian CarcinomaElaine Stur, Emine Bayraktar, Graziela Zibetti Dal Molin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 2015
A Phase I/II Study of the mTOR Inhibitor Everolimus in Combination with HyperCVAD Chemotherapy in Patients with Relapsed/Refractory Acute Lymphoblastic LeukemiaNaval Daver, Yanis Boumber, Hagop Kantarjian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 4, 2014
Preclinical and early clinical evaluation of the oral AKT inhibitor, MK-2206, for the treatment of acute myelogenous leukemiaMarina Y Konopleva, Roland B Walter, Stefan H Faderl, et al.
Pageof 10